Humatech Stock EBITDA
| HUMT Stock | USD 0.0001 0.00 0.00% |
Humatech fundamentals help investors to digest information that contributes to Humatech's financial success or failures. It also enables traders to predict the movement of Humatech Stock. The fundamental analysis module provides a way to measure Humatech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Humatech stock.
Humatech | EBITDA |
Humatech Company EBITDA Analysis
Humatech's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Humatech EBITDA | (499.67 K) |
Most of Humatech's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Humatech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Humatech EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Humatech is extremely important. It helps to project a fair market value of Humatech Stock properly, considering its historical fundamentals such as EBITDA. Since Humatech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Humatech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Humatech's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Humatech reported earnings before interest,tax, depreciation and amortization of (499,670). This is 100.06% lower than that of the Chemicals sector and 100.05% lower than that of the Materials industry. The ebitda for all United States stocks is 100.01% higher than that of the company.
Humatech EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Humatech's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Humatech could also be used in its relative valuation, which is a method of valuing Humatech by comparing valuation metrics of similar companies.Humatech is currently under evaluation in ebitda category among its peers.
Humatech Fundamentals
| Return On Asset | -1.01 | ||||
| Profit Margin | (0.46) % | ||||
| Operating Margin | (0.38) % | ||||
| Current Valuation | 9.5 K | ||||
| Shares Outstanding | 95 M | ||||
| Price To Earning | (0.24) X | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 1.57 M | ||||
| Gross Profit | 499.39 K | ||||
| EBITDA | (499.67 K) | ||||
| Net Income | (700.99 K) | ||||
| Cash And Equivalents | 3.36 K | ||||
| Total Debt | 285.33 K | ||||
| Current Ratio | 0.11 X | ||||
| Book Value Per Share | (0.04) X | ||||
| Cash Flow From Operations | 4.22 K | ||||
| Beta | -9.21 | ||||
| Market Capitalization | 9.5 K | ||||
| Total Asset | 354.97 K | ||||
| Retained Earnings | (11.61 M) | ||||
| Working Capital | (1.22 M) | ||||
| Current Asset | 250 K | ||||
| Current Liabilities | 1.47 M | ||||
| Net Asset | 354.97 K |
About Humatech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Humatech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humatech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humatech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Humatech Stock Analysis
When running Humatech's price analysis, check to measure Humatech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humatech is operating at the current time. Most of Humatech's value examination focuses on studying past and present price action to predict the probability of Humatech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humatech's price. Additionally, you may evaluate how the addition of Humatech to your portfolios can decrease your overall portfolio volatility.